Your browser doesn't support javascript.
loading
TET2 and TET3 loss disrupts small intestine differentiation and homeostasis.
Ansari, Ihab; Solé-Boldo, Llorenç; Ridnik, Meshi; Gutekunst, Julian; Gilliam, Oliver; Korshko, Maria; Liwinski, Timur; Jickeli, Birgit; Weinberg-Corem, Noa; Shoshkes-Carmel, Michal; Pikarsky, Eli; Elinav, Eran; Lyko, Frank; Bergman, Yehudit.
  • Ansari I; Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem, Israel.
  • Solé-Boldo L; Division of Epigenetics, DKFZ-ZMBH Alliance, German Cancer Research Center, Heidelberg, Germany.
  • Ridnik M; Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem, Israel.
  • Gutekunst J; Division of Epigenetics, DKFZ-ZMBH Alliance, German Cancer Research Center, Heidelberg, Germany.
  • Gilliam O; Division of Epigenetics, DKFZ-ZMBH Alliance, German Cancer Research Center, Heidelberg, Germany.
  • Korshko M; Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem, Israel.
  • Liwinski T; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel.
  • Jickeli B; University Psychiatric Clinics Basel, Clinic for Adults, University of Basel, Basel, Switzerland.
  • Weinberg-Corem N; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel.
  • Shoshkes-Carmel M; Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem, Israel.
  • Pikarsky E; Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem, Israel.
  • Elinav E; The Lautenberg Center for Immunology, Institute for Medical Research Israel-Canada, Hebrew University Medical School, Jerusalem, Israel.
  • Lyko F; Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel.
  • Bergman Y; Division of Microbiome and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Nat Commun ; 14(1): 4005, 2023 07 06.
Article en En | MEDLINE | ID: mdl-37414790
ABSTRACT
TET2/3 play a well-known role in epigenetic regulation and mouse development. However, their function in cellular differentiation and tissue homeostasis remains poorly understood. Here we show that ablation of TET2/3 in intestinal epithelial cells results in a murine phenotype characterized by a severe homeostasis imbalance in the small intestine. Tet2/3-deleted mice show a pronounced loss of mature Paneth cells as well as fewer Tuft and more Enteroendocrine cells. Further results show major changes in DNA methylation at putative enhancers, which are associated with cell fate-determining transcription factors and functional effector genes. Notably, pharmacological inhibition of DNA methylation partially rescues the methylation and cellular defects. TET2/3 loss also alters the microbiome, predisposing the intestine to inflammation under homeostatic conditions and acute inflammation-induced death. Together, our results uncover previously unrecognized critical roles for DNA demethylation, possibly occurring subsequently to chromatin opening during intestinal development, culminating in the establishment of normal intestinal crypts.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Epigénesis Genética / Dioxigenasas Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Epigénesis Genética / Dioxigenasas Límite: Animals Idioma: En Año: 2023 Tipo del documento: Article